Novel targets for immunotherapy in glomerulonephritis

Abstract

Glomerulonephritis is a common cause of chronic kidney disease and end stage renal failure. Current therapy relies on variably effective, nonspecific and toxic immunosuppression. Recent insights into underlying biology and disease pathogenesis in human glomerulonephritis combined with advances in the fields of inflammation and autoimmunity promise a cadre… (More)

Topics

4 Figures and Tables

Slides referencing similar topics